Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Computational epitope profiling and AI-driven protein engineering enable rational design of multi-epitope vaccines against Mycobacterium tuberculosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Tuberculosis
10.1038/nrdp.2016.76 · 2016 · External reference
10.1038/s41579-024-01025-1
10.1038/s41579-024-01025-1 · External reference
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline
10.1016/s2666-5247(22)00303-2 · 2023 · External reference
10.1016/s1473-3099(21)00403-5
10.1016/s1473-3099(21)00403-5 · External reference
The success and failure of BCG - implications for a novel tuberculosis vaccine
10.1038/nrmicro1211 · 2005 · External reference
10.1016/s1473-3099(19)30625-5
10.1016/s1473-3099(19)30625-5 · External reference
Tuberculosis vaccine development: progress in clinical evaluation
10.1128/cmr.00100-19 · 2019 · External reference
DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies
10.3389/fimmu.2024.1457327 · 2024 · External reference
10.1038/s41590-023-01715-7
10.1038/s41590-023-01715-7 · External reference
10.1038/s41577-020-00479-7
10.1038/s41577-020-00479-7 · External reference
Development and evaluation of a multi-epitope subunit vaccine against Mycoplasma synoviae infection
10.1016/j.ijbiomac.2023.126685 · 2023 · External reference
Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection
10.1080/22221751.2022.2122585 · 2022 · External reference
10.1021/acsnano.3c01829
10.1021/acsnano.3c01829 · External reference
10.1021/acsnano.4c03075
10.1021/acsnano.4c03075 · External reference
Immunoinformatics-based potential multi-peptide vaccine designing against jamestown canyon virus (JCV) capable of eliciting cellular and humoral immune responses
10.1016/j.ijbiomac.2023.126678 · 2023 · External reference
Towards specie-specific ensemble vaccine candidates against mammarenaviruses using optimized structural vaccinology pipeline and molecular modelling approaches
10.1016/j.micpath.2022.105793 · 2022 · External reference
Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: insights into binding stability and immunological memory
10.1016/j.heliyon.2024.e36154 · 2024 · External reference
10.1016/j.csbj.2023.01.019
10.1016/j.csbj.2023.01.019 · External reference
In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis
10.3389/fimmu.2024.1474346 · 2024 · External reference
In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology
10.1038/s41598-020-80899-6 · 2021 · External reference
In silico designed novel multi-epitope mRNA vaccines against brucella by targeting extracellular protein BtuB and LptD
10.1038/s41598-024-57793-6 · 2024 · External reference
Immunoinformatics-guided design of a multi-valent vaccine against rotavirus and norovirus (ChRNV22)
10.1016/j.compbiomed.2023.106941 · 2023 · External reference
Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection
10.3389/fimmu.2024.1425603 · 2024 · External reference
Immunoinformatics-based multi-epitope containing fused polypeptide vaccine design against visceral leishmaniasis with high immunogenicity and TLR binding
10.1016/j.ijbiomac.2023.127567 · 2023 · External reference
Development of innovative multi-epitope mRNA vaccine against Pseudomonas aeruginosa using in silico approaches
10.1093/bib/bbad502 · 2023 · External reference
10.1016/j.molliq.2022.118633
10.1016/j.molliq.2022.118633 · External reference
10.1016/j.micpath.2021.105161
10.1016/j.micpath.2021.105161 · External reference
10.1016/j.heliyon.2024.e34721
10.1016/j.heliyon.2024.e34721 · External reference
in silico vaccine design. A tutorial in immunoinformatics
2022 · External reference
The Immune Epitope Database (IEDB): 2024 update
10.1093/nar/gkae1092 · 2024 · External reference
10.1093/nar/gkaa379
10.1093/nar/gkaa379 · External reference
From good to better: comparative epitope profiling facilitates rational design of effective multi-epitope vaccines against viruses
10.1002/jmv.70366 · 2025 · External reference
the universal protein knowledgebase in 2025
2024 · External reference
Multistate and functional protein design using RoseTTAFold sequence space diffusion
10.1038/s41587-024-02395-w · 2024 · External reference
10.1093/nar/gkab1061
10.1093/nar/gkab1061 · External reference
10.1038/s41586-023-06415-8
10.1038/s41586-023-06415-8 · External reference
10.1126/science.add2187
10.1126/science.add2187 · External reference
10.1038/s41586-024-07487-w
10.1038/s41586-024-07487-w · External reference
10.1093/nar/gkz297
10.1093/nar/gkz297 · External reference
PDBsum extras: SARS-CoV-2 and AlphaFold models
10.1002/pro.4238 · 2022 · External reference
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
10.1186/1471-2105-8-4 · 2007 · External reference
10.1093/bioinformatics/btq551
10.1093/bioinformatics/btq551 · External reference
10.1093/nar/gki396
10.1093/nar/gki396 · External reference
SoluProt: prediction of soluble protein expression in Escherichia coli
10.1093/bioinformatics/btaa1102 · 2021 · External reference
SOLpro: accurate sequence-based prediction of protein solubility
10.1093/bioinformatics/btp386 · 2009 · External reference
AllerTOP v.2--a server for in silico prediction of allergens
10.1007/s00894-014-2278-5 · 2014 · External reference
Protein identification and analysis tools on the ExPASy server
10.1385/1-59259-890-0:571 · 2005 · External reference
10.1016/j.bpj.2011.10.024
10.1016/j.bpj.2011.10.024 · External reference
JMJJoac. PROCHECK: a program to check the stereochemical quality of protein structures
10.1107/s0021889892009944 · 1993 · External reference
10.1002/pro.3330
10.1002/pro.3330 · External reference
10.1093/nar/gkm290
10.1093/nar/gkm290 · External reference
10.1093/nar/gkx407
10.1093/nar/gkx407 · External reference
10.1093/bioinformatics/btw514
10.1093/bioinformatics/btw514 · External reference
10.1063/5.0018516
10.1063/5.0018516 · External reference
Immune system simulation online
10.1093/bioinformatics/btr335 · 2011 · External reference
The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation
10.1006/biol.2001.0297 · 2001 · External reference
10.1126/science.1075565
10.1126/science.1075565 · External reference
10.1097/moh.0000000000000005
10.1097/moh.0000000000000005 · External reference
10.1111/j.1600-065x.2011.01082.x
10.1111/j.1600-065x.2011.01082.x · External reference
10.1016/j.cell.2023.12.028
10.1016/j.cell.2023.12.028 · External reference
10.1126/science.adl2528
10.1126/science.adl2528 · External reference
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
10.1038/s41541-021-00391-8 · 2021 · External reference
Viral proteins recognized by different TLRs
10.1002/jmv.27265 · 2021 · External reference
10.1016/j.chom.2023.05.017
10.1016/j.chom.2023.05.017 · External reference
10.1038/s41579-021-00573-0
10.1038/s41579-021-00573-0 · External reference
Multi-epitope vaccine design against monkeypox virus via reverse vaccinology method exploiting immunoinformatic and bioinformatic approaches
10.3390/vaccines10122010 · 2022 · External reference
Identification of novel candidate epitopes on SARS-CoV-2 proteins for South America: a review of HLA frequencies by country
10.3389/fimmu.2020.02008 · 2020 · External reference
High resolution class I HLA-A, -B, and -C diversity in Eastern and Southern African populations
10.1038/s41598-025-06704-4 · 2025 · External reference
10.1038/nature22976
10.1038/nature22976 · External reference
10.1016/j.csbj.2022.10.002 · Admitted local publication
Immmunoinformatics-based design of T and B-cell multi-epitope vaccine to combat Borrelia burgdorferi infection
10.1016/j.ijbiomac.2025.143347 · 2025 · External reference
An immunoinformatics-based designed multi-epitope candidate vaccine (mpme-VAC/STV-1) against Mycoplasma pneumoniae
10.1016/j.compbiomed.2021.105194 · 2022 · External reference
Structural immunoinformatics approach for rational design of a multi-epitope vaccine against triple negative breast cancer
10.1016/j.ijbiomac.2023.125209 · 2023 · External reference
Design of a multi-epitope vaccine candidate against carrion disease by immunoinformatics approach
10.1016/j.compbiomed.2024.109397 · 2024 · External reference
10.1038/s41586-024-07487-w
10.1038/s41586-024-07487-w · External reference
10.1038/s41586-021-03819-2
10.1038/s41586-021-03819-2 · External reference
10.1021/acs.jctc.7b00125
10.1021/acs.jctc.7b00125 · External reference
Dimer-monomer transition defines a hyper-thermostable peptidoglycan hydrolase mined from bacterial proteome by lysin-derived antimicrobial peptide-primed screening
10.7554/elife.98266 · 2024 · External reference
Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions
10.1093/jac/dkad059 · 2023 · External reference
10.1016/j.abb.2012.09.008
10.1016/j.abb.2012.09.008 · External reference
Differential scanning calorimetry
10.1016/s0091-679x(07)84005-2 · 2008 · External reference
10.1038/s41423-023-01083-0
10.1038/s41423-023-01083-0 · External reference
10.1038/s41467-023-38751-8
10.1038/s41467-023-38751-8 · External reference
Enzyme-linked immunosorbent assay: types and applications
10.1007/978-1-0716-2903-1_1 · 2023 · External reference
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals
10.1038/s41467-023-41587-x · 2023 · External reference
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
10.1136/annrheumdis-2021-220626 · 2021 · External reference
ELISPOT techniques
10.1007/7651_2014_111 · 2016 · External reference
A bacteriophage-based, highly efficacious, needle- and adjuvant-free, mucosal COVID-19 vaccine
10.1128/mbio.01822-22 · 2022 · External reference
Changing route: aerosol vaccine against tuberculosis
10.1016/s1473-3099(14)70886-2 · 2014 · External reference
10.1038/s41467-021-26934-0
10.1038/s41467-021-26934-0 · External reference
10.1046/j.1365-2958.2002.03237.x
10.1046/j.1365-2958.2002.03237.x · External reference
10.1046/j.1365-2958.2003.03844.x
10.1046/j.1365-2958.2003.03844.x · External reference